Stay updated on Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial

Sign up to get notified when there's something new on the Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    This updates the site’s displayed revision/version number from v3.5.2 to v3.5.3, reflecting a minor platform release rather than a change to the study record content.
    Difference
    0.1%
    Check dated 2026-04-24T06:17:10.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:39:18.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    Added 'Ovarian cancer' as a topic and 'MedlinePlus Genetics' as a related topic on the study page.
    Difference
    0.2%
    Check dated 2026-03-26T11:37:46.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0. Deleted: Ovarian cancer and MedlinePlus Genetics topics, as well as Revision: v3.4.3.
    Difference
    0.2%
    Check dated 2026-03-19T04:53:07.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The page revision has been updated from v3.4.2 to v3.4.3, with no other content changes indicated.
    Difference
    0.1%
    Check dated 2026-03-12T02:29:25.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    Added Primary peritoneal carcinoma to the study context and introduced the Genetic and Rare Diseases Information Center resource. Removed the government funding lapse notice and updated the revision to v3.4.2.
    Difference
    0.6%
    Check dated 2026-02-11T12:18:22.000Z thumbnail image

Stay in the know with updates to Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial page.